Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.

Lang J, Cheng Y, Rolfe A, Hammack C, Vera D, Kyle K, Wang J, Meissner TB, Ren Y, Cowan C, Tang H.

Stem Cell Reports. 2018 Jun 27. pii: S2213-6711(18)30269-8. doi: 10.1016/j.stemcr.2018.06.006. [Epub ahead of print]

2.

Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.

Klingmann V, Linderskamp H, Meissner T, Mayatepek E, Moeltner A, Breitkreutz J, Bosse HM.

J Pediatr. 2018 Jun 27. pii: S0022-3476(18)30744-3. doi: 10.1016/j.jpeds.2018.05.031. [Epub ahead of print]

PMID:
29960767
3.

COPD-Patienten aktivieren.

Meißner T.

MMW Fortschr Med. 2018 May;160(10):67. doi: 10.1007/s15006-018-0587-9. German. No abstract available.

PMID:
29855897
4.

Detection of Cross-Sample Contamination in Multiple Myeloma Samples and Sequencing Data.

Stephens OW, Meißner T, Weinhold N.

Methods Mol Biol. 2018;1792:147-155. doi: 10.1007/978-1-4939-7865-6_10.

PMID:
29797257
5.

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.

Ali M, Ajore R, Wihlborg AK, Niroula A, Swaminathan B, Johnsson E, Stephens OW, Morgan G, Meissner T, Turesson I, Goldschmidt H, Mellqvist UH, Gullberg U, Hansson M, Hemminki K, Nahi H, Waage A, Weinhold N, Nilsson B.

Nat Commun. 2018 Apr 25;9(1):1649. doi: 10.1038/s41467-018-04082-2.

6.

Using unique surface patterns of injection moulded plastic components as an image based Physical Unclonable Function for secure component identification.

Wigger B, Meissner T, Förste A, Jetter V, Zimmermann A.

Sci Rep. 2018 Mar 16;8(1):4738. doi: 10.1038/s41598-018-22876-8.

7.

Interleukin-7 receptor α-chain haplotypes differentially affect soluble IL-7 receptor and IL-7 serum concentrations in children with type 1 diabetes.

Seyfarth J, Lundtoft C, Förtsch K, Ahlert H, Rosenbauer J, Baechle C, Roden M, Holl RW, Mayatepek E, Kummer S, Meissner T, Jacobsen M.

Pediatr Diabetes. 2018 Aug;19(5):955-962. doi: 10.1111/pedi.12665. Epub 2018 Mar 13.

PMID:
29484785
8.

CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility.

Seyfarth J, Ahlert H, Rosenbauer J, Baechle C, Roden M, Holl RW, Mayatepek E, Meissner T, Jacobsen M.

Mol Cell Pediatr. 2018 Feb 6;5(1):2. doi: 10.1186/s40348-018-0080-7.

9.

Correction: Reinauer et al., The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype. Genes 2017, 8, 146.

Reinauer C, Rosenbauer J, Bächle C, Herder C, Roden M, Ellard S, De Franco E, Karges B, Holl RW, Enczmann J, Meissner T.

Genes (Basel). 2018 Jan 3;9(1). pii: E13. doi: 10.3390/genes9010013.

10.

Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes.

Reinauer C, Reinehr T, Baechle C, Karges B, Seyfarth J, Foertsch K, Schebek M, Woelfle J, Roden M, Holl RW, Rosenbauer J, Meissner T.

Horm Res Paediatr. 2018;89(2):73-81. doi: 10.1159/000484896. Epub 2017 Dec 5.

PMID:
29207397
11.

Formal Neurocognitive Testing in 60 Patients with Congenital Hyperinsulinism.

Ludwig A, Enke S, Heindorf J, Empting S, Meissner T, Mohnike K.

Horm Res Paediatr. 2018;89(1):1-6. doi: 10.1159/000481774. Epub 2017 Nov 17.

PMID:
29151084
12.

Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.

Seyfarth J, Reinehr T, Hoyer A, Reinauer C, Bächle C, Karges B, Mayatepek E, Roden M, Hofer SE, Wiegand S, Woelfle J, Kiess W, Rosenbauer J, Holl RW, Meissner T.

J Inherit Metab Dis. 2018 Jan;41(1):73-79. doi: 10.1007/s10545-017-0100-0. Epub 2017 Oct 13.

PMID:
29027597
13.

Mind the Hype: A Critical Evaluation and Prescriptive Agenda for Research on Mindfulness and Meditation.

Van Dam NT, van Vugt MK, Vago DR, Schmalzl L, Saron CD, Olendzki A, Meissner T, Lazar SW, Kerr CE, Gorchov J, Fox KCR, Field BA, Britton WB, Brefczynski-Lewis JA, Meyer DE.

Perspect Psychol Sci. 2018 Jan;13(1):36-61. doi: 10.1177/1745691617709589. Epub 2017 Oct 10.

PMID:
29016274
14.

Reiterated Concerns and Further Challenges for Mindfulness and Meditation Research: A Reply to Davidson and Dahl.

Van Dam NT, van Vugt MK, Vago DR, Schmalzl L, Saron CD, Olendzki A, Meissner T, Lazar SW, Gorchov J, Fox KCR, Field BA, Britton WB, Brefczynski-Lewis JA, Meyer DE.

Perspect Psychol Sci. 2018 Jan;13(1):66-69. doi: 10.1177/1745691617727529. Epub 2017 Oct 10.

PMID:
29016240
15.

Polycystic Ovary Syndrome (PCOS) in Juvenile and Adult Type 1 Diabetes in a German/Austrian Cohort.

Reinauer C, Bollow E, Fröhlich-Reiterer E, Laubner K, Bergis D, Schöfl C, Kempe HP, Hummel M, Hennes P, Gollisch K, Haberland H, Datz N, Meissner T, Holl RW.

Exp Clin Endocrinol Diabetes. 2017 Nov;125(10):661-668. doi: 10.1055/s-0043-104701. Epub 2017 Sep 19.

PMID:
28926868
16.

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism.

Li N, Johnson DC, Weinhold N, Kimber S, Dobbins SE, Mitchell JS, Kinnersley B, Sud A, Law PJ, Orlando G, Scales M, Wardell CP, Försti A, Hoang PH, Went M, Holroyd A, Hariri F, Pastinen T, Meissner T, Goldschmidt H, Hemminki K, Morgan GJ, Kaiser M, Houlston RS.

Cell Rep. 2017 Sep 12;20(11):2556-2564. doi: 10.1016/j.celrep.2017.08.062.

17.

NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.

Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E.

Diabetes Obes Metab. 2017 Sep;19 Suppl 1:95-106. doi: 10.1111/dom.13017. Review.

PMID:
28880473
18.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C, Bauer M, Stein C, Deshpande S, Wardell C, Buzder T, Molnar G, Zangari M, van Rhee F, Thanendrarajan S, Schinke C, Epstein J, Davies FE, Walker BA, Meissner T, Barlogie B, Morgan GJ, Weinhold N.

Nat Commun. 2017 Aug 16;8(1):268. doi: 10.1038/s41467-017-00296-y.

19.

Humanisierter Antikörper killt Eosinophile.

Meißner T.

MMW Fortschr Med. 2017 Jul;159(13):73. doi: 10.1007/s15006-017-9913-x. German. No abstract available.

PMID:
28718105
20.

Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.

Meißner T, Mark A, Williams C, Berdel WE, Wiebe S, Kerkhoff A, Wardelmann E, Gaiser T, Müller-Tidow C, Rosenstiel P, Arnold N, Leyland-Jones B, Franke A, Stanulla M, Forster M.

Cold Spring Harb Mol Case Stud. 2017 Jul 5;3(4). pii: a001677. doi: 10.1101/mcs.a001677. Print 2017 Jul.

21.

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism.

Corda H, Kummer S, Welters A, Teig N, Klee D, Mayatepek E, Meissner T.

Orphanet J Rare Dis. 2017 Jun 2;12(1):108. doi: 10.1186/s13023-017-0653-x.

22.

Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.

Leiter SM, Parker VER, Welters A, Knox R, Rocha N, Clark G, Payne F, Lotta L, Harris J, Guerrero-Fernández J, González-Casado I, García-Miñaur S, Gordo G, Wareham N, Martínez-Glez V, Allison M, O'Rahilly S, Barroso I, Meissner T, Davies S, Hussain K, Temple K, Barreda-Bonis AC, Kummer S, Semple RK.

Eur J Endocrinol. 2017 Aug;177(2):175-186. doi: 10.1530/EJE-17-0132. Epub 2017 May 31.

23.

The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype.

Reinauer C, Rosenbauer J, Bächle C, Herder C, Roden M, Ellard S, De Franco E, Karges B, Holl RW, Enczmann J, Meissner T.

Genes (Basel). 2017 May 19;8(5). pii: E146. doi: 10.3390/genes8050146. Erratum in: Genes (Basel). 2018 Jan 03;9(1):.

24.

Tracking the Functional Development of the Corpus Callosum in Children Using Behavioral and Evoked Potential Interhemispheric Transfer Times.

Meissner TW, Friedrich P, Ocklenburg S, Genç E, Weigelt S.

Dev Neuropsychol. 2017;42(3):172-186. doi: 10.1080/87565641.2017.1315582. Epub 2017 May 12.

PMID:
28498015
25.

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.

Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, Thanendrarajan S, Schinke C, Samant R, Yaccoby S, Walker BA, Epstein J, Zangari M, van Rhee F, Meissner T, Goldschmidt H, Hemminki K, Houlston R, Barlogie B, Davies FE, Morgan GJ, Weinhold N.

Blood. 2017 Jul 6;130(1):30-34. doi: 10.1182/blood-2017-03-774422. Epub 2017 Apr 21.

26.

[The Use of Interpreters in the Work with Refugee Children, Adolescents, their Families and Key Persons in Psychotherapeutic Care System].

Kießl G, Meißner T, Romer G, Möller B.

Prax Kinderpsychol Kinderpsychiatr. 2017 Apr;66(4):304-312. doi: 10.13109/prkk.2017.66.4.304. German.

PMID:
28393642
27.

Dominant TNFα and impaired IL-2 cytokine profiles of CD4+ T cells from children with type-1 diabetes.

Seyfarth J, Förtsch K, Ahlert H, Laws HJ, Karges B, Deenen R, Köhrer K, Mayatepek E, Meissner T, Jacobsen M.

Immunol Cell Biol. 2017 Aug;95(7):630-639. doi: 10.1038/icb.2017.24. Epub 2017 Apr 5.

PMID:
28377612
28.

NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.

Tilburgs T, Meissner TB, Ferreira LMR, Mulder A, Musunuru K, Ye J, Strominger JL.

Biol Reprod. 2017 Apr 1;96(4):831-842. doi: 10.1093/biolre/iox009.

29.

HLA-G: At the Interface of Maternal-Fetal Tolerance.

Ferreira LMR, Meissner TB, Tilburgs T, Strominger JL.

Trends Immunol. 2017 Apr;38(4):272-286. doi: 10.1016/j.it.2017.01.009. Epub 2017 Mar 6. Review.

PMID:
28279591
30.

Use of activity tracking in major visceral surgery-the Enhanced Perioperative Mobilization (EPM) trial: study protocol for a randomized controlled trial.

Wolk S, Meißner T, Linke S, Müssle B, Wierick A, Bogner A, Sturm D, Rahbari NN, Distler M, Weitz J, Welsch T.

Trials. 2017 Feb 21;18(1):77. doi: 10.1186/s13063-017-1782-1.

31.

Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.

Kummer S, Klee D, Kircheis G, Friedt M, Schaper J, Häussinger D, Mayatepek E, Meissner T.

Eur J Pediatr. 2017 Apr;176(4):529-536. doi: 10.1007/s00431-017-2876-1. Epub 2017 Feb 17.

PMID:
28213828
32.

Achten Sie auf den Immunstatus!

Meißner T.

MMW Fortschr Med. 2017 Feb;159(2):67. doi: 10.1007/s15006-017-9226-0. German. No abstract available.

PMID:
28168458
33.

Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability.

Anikster Y, Haack TB, Vilboux T, Pode-Shakked B, Thöny B, Shen N, Guarani V, Meissner T, Mayatepek E, Trefz FK, Marek-Yagel D, Martinez A, Huttlin EL, Paulo JA, Berutti R, Benoist JF, Imbard A, Dorboz I, Heimer G, Landau Y, Ziv-Strasser L, Malicdan MCV, Gemperle-Britschgi C, Cremer K, Engels H, Meili D, Keller I, Bruggmann R, Strom TM, Meitinger T, Mullikin JC, Schwartz G, Ben-Zeev B, Gahl WA, Harper JW, Blau N, Hoffmann GF, Prokisch H, Opladen T, Schiff M.

Am J Hum Genet. 2017 Feb 2;100(2):257-266. doi: 10.1016/j.ajhg.2017.01.002. Epub 2017 Jan 26.

34.

Need for Better Diabetes Treatment: The Therapeutic Potential of NMDA Receptor Antagonists.

Welters A, Lammert E, Mayatepek E, Meissner T.

Klin Padiatr. 2017 Jan;229(1):14-20. doi: 10.1055/s-0042-117831. Epub 2016 Dec 14. Review.

PMID:
27975343
35.

Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.

Taylan C, Schlune A, Meissner T, Ažukaitis K, Udink Ten Cate FE, Weber LT.

J Clin Lipidol. 2016 Nov - Dec;10(6):1303-1310. doi: 10.1016/j.jacl.2016.08.006. Epub 2016 Aug 20.

PMID:
27919346
36.

Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.

Paul DS, Teschendorff AE, Dang MA, Lowe R, Hawa MI, Ecker S, Beyan H, Cunningham S, Fouts AR, Ramelius A, Burden F, Farrow S, Rowlston S, Rehnstrom K, Frontini M, Downes K, Busche S, Cheung WA, Ge B, Simon MM, Bujold D, Kwan T, Bourque G, Datta A, Lowy E, Clarke L, Flicek P, Libertini E, Heath S, Gut M, Gut IG, Ouwehand WH, Pastinen T, Soranzo N, Hofer SE, Karges B, Meissner T, Boehm BO, Cilio C, Elding Larsson H, Lernmark Å, Steck AK, Rakyan VK, Beck S, Leslie RD.

Nat Commun. 2016 Nov 29;7:13555. doi: 10.1038/ncomms13555.

37.

Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression.

Li N, Johnson DC, Weinhold N, Studd JB, Orlando G, Mirabella F, Mitchell JS, Meissner T, Kaiser M, Goldschmidt H, Hemminki K, Morgan GJ, Houlston RS.

Nat Commun. 2016 Nov 24;7:13656. doi: 10.1038/ncomms13656.

38.

Towards sensible toxicity testing for nanomaterials: proposal for the specification of test design.

Potthoff A, Weil M, Meißner T, Kühnel D.

Sci Technol Adv Mater. 2015 Dec 9;16(6):065006. eCollection 2015 Dec.

39.

Oxidized Carbo-Iron causes reduced reproduction and lower tolerance of juveniles in the amphipod Hyalella azteca.

Weil M, Meißner T, Springer A, Bundschuh M, Hübler L, Schulz R, Duis K.

Aquat Toxicol. 2016 Dec;181:94-103. doi: 10.1016/j.aquatox.2016.10.028. Epub 2016 Nov 2.

PMID:
27825064
40.

Leberfibrose muss überwacht und gegebenenfalls therapiert werden.

Meißner T.

MMW Fortschr Med. 2016 Nov;158(Suppl 3):95. German. No abstract available.

PMID:
27822800
41.

Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.

Grasemann C, Unger N, Hövel M, Arweiler-Harbeck D, Herrmann R, Schündeln MM, Müller O, Schweiger B, Lausch E, Meissner T, Kiewert C, Hauffa BP, Shaw NJ.

J Clin Endocrinol Metab. 2017 Jan 1;102(1):210-219. doi: 10.1210/jc.2016-2905.

PMID:
27809640
42.

Reply to: mitochondrial diabetes in Germany and Austria.

Reinauer C, Meissner T, Roden M, Thon A, Holterhus PM, Haberland H, Binder E, Marg W, Bollow E, Holl R.

Eur J Pediatr. 2016 Dec;175(12):2025-2026. Epub 2016 Sep 23. No abstract available.

PMID:
27664162
43.

Chance auf verbesserten Visus.

Meißner T.

MMW Fortschr Med. 2016 Aug;158(14):73. doi: 10.1007/s15006-016-8601-6. German. No abstract available.

PMID:
27525804
44.

Erstes spezifisches Antidot für Dabigatran.

Meißner T.

MMW Fortschr Med. 2016 Aug;158(14):72. doi: 10.1007/s15006-016-8598-x. German. No abstract available.

PMID:
27525801
45.

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

Weinhold N, Ashby C, Rasche L, Chavan SS, Stein C, Stephens OW, Tytarenko R, Bauer MA, Meissner T, Deshpande S, Patel PH, Buzder T, Molnar G, Peterson EA, van Rhee F, Zangari M, Thanendrarajan S, Schinke C, Tian E, Epstein J, Barlogie B, Davies FE, Heuck CJ, Walker BA, Morgan GJ.

Blood. 2016 Sep 29;128(13):1735-44. doi: 10.1182/blood-2016-06-723007. Epub 2016 Aug 11.

46.

[Extended protection with Efmoroctocog alfa].

Meißner T.

MMW Fortschr Med. 2016 Jun 23;158(12):74. German. No abstract available.

PMID:
27462665
47.

U Can Touch This: How Tablets Can Be Used to Study Cognitive Development.

Semmelmann K, Nordt M, Sommer K, Röhnke R, Mount L, Prüfer H, Terwiel S, Meissner TW, Koldewyn K, Weigelt S.

Front Psychol. 2016 Jul 7;7:1021. doi: 10.3389/fpsyg.2016.01021. eCollection 2016.

48.

[Causal therapy is available].

Meißner T.

MMW Fortschr Med. 2016 Jun 23;158(12):74. doi: 10.1007/s15006-016-8458-8. German. No abstract available.

PMID:
27324018
49.

Verlängerter Schutz durch Efmoroctocog alfa.

Meißner T.

MMW Fortschr Med. 2016 Jun;158(12):74. doi: 10.1007/s15006-016-8457-9. German. No abstract available.

PMID:
28924926
50.

NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, Sidiq T, Shipp MA, Lizee GA, Kobayashi KS.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.

Supplemental Content

Loading ...
Support Center